Actively Recruiting
Delineation of Target Volume of Stereotactic Radiotherapy for Spinal Tumors
Led by Peking University Third Hospital · Updated on 2024-09-19
500
Participants Needed
1
Research Sites
573 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study was to compare efficacy and side effects of two target delineation methods for stereotactic radiotherapy of metastatic spinal tumors.
CONDITIONS
Official Title
Delineation of Target Volume of Stereotactic Radiotherapy for Spinal Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with spinal metastases or primary tumors receiving stereotactic radiotherapy
- Patients with sufficient pre-treatment imaging data
- Patients who can cooperate with imaging review and follow-up after radiotherapy
You will not qualify if you...
- Patients with an expected survival of less than 3 months
- Patients with second-course radiotherapy
- Patients with physical conditions that cannot tolerate stereotactic radiotherapy
- Patients with extensive spinal metastasis and no local therapeutic value
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Radiation Oncology Cancer Center, Peking University Third Hospital 49# North Garden Rd.,Haidian Dist.
Beijing, Beijing Municipality, China, 100191
Actively Recruiting
Research Team
H
Hongqing Zhuang, Doctor
CONTACT
Y
Yuxia Wang
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here